Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Improved glycemic control achieved with repaglinide plus pioglitazone in type 2 diabetes

March 8, 2004

French team identifies ghrelin analogues as GHS receptor ligands

March 5, 2004

New glucocorticoid receptor modulators covered by BMS patent

March 5, 2004

Abbott and Millennium identify melanocortin receptor antagonist for disease-associated weight loss

March 4, 2004

Lilly to advance LY-519818 into registrational studies

March 4, 2004

Complementary effects of rosiglitazone and metformin in type 2 diabetes

March 4, 2004

Investigation of Viagra for FSAD to close

March 3, 2004

Two novel series of glycogenphosphorylase a inhibitors under study at Aventis

March 3, 2004

Aventis claims the preparation and use of novel cysteine protease inhibitors

March 3, 2004

New glucosylceramide synthase inhibitors identified at Oxford Glycosciences

March 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...